[1]
|
Zheng, C., Chen, Z., Zhang, L., et al. (2019) Metabolic Risk Factors and Left Ventricular Diastolic Function in Mid-dle-Aged Chinese Living in the Tibetan Plateau. Journal of the American Heart Association, 8, e010454.
https://doi.org/10.1161/JAHA.118.010454
|
[2]
|
宋晶慧, 邹登朗, 祁得胜, 等. 高原低氧环境对心肌细胞影响的研究进展[J]. 生态科学, 2023, 42(4): 258-264.
https://doi.org/10.14108/j.cnki.1008-8873.2023.04.030
|
[3]
|
吴兆琦, 陈永清. 高原环境对人心脏结构功能的影响[J]. 西北国防医学杂志, 2020, 41(12): 760-763.
https://doi.org/10.16021/j.cnki.1007-8622.2020.12.007
|
[4]
|
关于我国高原病命名、分型及诊断标准(1995年中华医学会标准)及其英译本的介绍[J]. 高原医学杂志, 2010, 20(1): 5-9.
|
[5]
|
努尔比叶木∙麦麦提艾力, 张艳君, 牛明远, 等. 高原地区心功能不全患者临床特征及心室扩大危险因素的观察性研究[J]. 临床心血管病杂志, 2022, 38(8): 659-664. https://doi.org/10.13201/j.issn.1001-1439.2022.08.012
|
[6]
|
盖祥云, 林鹏程, 何彦峰, 才让南加. 低氧性肺动脉高压中低氧性肺血管收缩的作用[J]. 中国药理学通报, 2016, 32(6): 768-772.
|
[7]
|
Dumas, J.P., Bardou, M., Goirand, F. and Dumas, M. (1999) Hypoxic Pulmonary Vasoconstriction. General Pharmacology, 33, 289-297. https://doi.org/10.1016/S0306-3623(99)00026-9
|
[8]
|
冯斌, 李苏雷, 陈韵岱, 杨庭树, 盖鲁粤. 高原心脏病[J]. 中华保健医学杂志, 2016, 18(3): 262-263.
|
[9]
|
Letourneau, M.M., Brancheau, D., Estes, J. and Zughaib, M. (2020) Take Me Higher: A Case of Heart Failure at High Altitude Detected Using the CardioMEMS™ HF System. American Journal of Case Reports, 21, e922857.
https://doi.org/10.12659/AJCR.922857
|
[10]
|
Xu, X.Q. and Jing, Z.C. (2009) High-Altitude Pulmonary Hyperten-sion. European Respiratory Review, 18, 13-17.
https://doi.org/10.1183/09059180.00011104
|
[11]
|
Firth, A.L., Won, J.Y. and Park, W.S. (2013) Regulation of Ca(2+) Signaling in Pulmonary Hypertension. The Korean Journal of Physiology & Pharmacology, 17, 1-8. https://doi.org/10.4196/kjpp.2013.17.1.1
|
[12]
|
Lai, N., Lu, W. and Wang, J. (2015) Ca(2+) and Ion Channels in Hypoxia-Mediated Pulmonary Hypertension. International Journal of Clinical and Experimental Pathology, 8, 1081-1092.
|
[13]
|
柏争鸣, 王栋军, 郑芳芳. 小儿高原性心脏病175例临床分析[J]. 西南军医, 2008, 10(3): 60-61.
|
[14]
|
关于统一使用慢性高原(山)病“青海标准”的决定[J]. 高原医学杂志, 2007, 17(1): 1-2.
|
[15]
|
马海红, 李洪英, 胡雪梅, 范娜. 彩色超声心动图检查在高原心脏病肺动脉高压诊断中的临床价值[J]. 中国医学装备, 2016, 13(10): 52-55.
|
[16]
|
孟莉, 鲍海华. 慢性高原心脏病的临床与影像诊断价值[J]. 高原医学杂志, 2014, 24(2): 57-59.
|
[17]
|
崔明霞. 超声心动图在诊断完全性肺静脉异位引流中的临床价值[J]. 中国初级卫生保健, 2012, 26(12): 115-116.
|
[18]
|
Galiè, N., Humbert, M., Vachiery, J.L., et al. (2016) 2015 ESC/ERS Guidelines for the Diagno-sis and Treatment of Pulmonary Hypertension. Revista Española de Cardiología (England Ed), 69, 177.e1-177.e62.
https://doi.org/10.1016/j.recesp.2016.01.002
|
[19]
|
韩泽乾, 董红梅, 罗勇军. 高原心脏病防治研究进展[J]. 人民军医, 2017, 60(8): 822-824.
|
[20]
|
Nieman, K. and Balla, S. (2020) Dynamic CT Myocardial Perfusion Imaging. Journal of Cardiovascular Computed Tomography, 14, 303-306. https://doi.org/10.1016/j.jcct.2019.09.003
|
[21]
|
周振, 徐磊, 范占明. 基于心脏CT的细胞外容积量化在弥漫性心肌纤维化中的研究进展[J]. 心肺血管病杂志, 2018, 37(7): 707-710.
|
[22]
|
张志杰, 曹剑, 王怡宁, 等. 高原性心脏病40例心脏磁共振表现分析[J]. 实用医学影像杂志, 2022, 23(6): 541-545. https://doi.org/10.16106/j.cnki.cn14-1281/r.2022.06.001
|
[23]
|
Russo, V., Lovato, L. and Ligabue, G. (2020) Cardiac MRI: Technical Basis. Radiologia Medica, 125, 1040-1055.
https://doi.org/10.1007/s11547-020-01282-z
|
[24]
|
Ambale-Venkatesh, B. and Lima, J.A. (2015) Cardiac MRI: A Central Prognostic Tool in Myocardial Fibrosis. Nature Reviews Cardiology, 12, 18-29. https://doi.org/10.1038/nrcardio.2014.159
|
[25]
|
Everett, R.J., Stirrat, C.G., Semple, S.I., Newby, D.E., Dweck, M.R. and Mirsadraee, S. (2016) Assessment of Myocardial Fibrosis with T1 Mapping MRI. Clinical Radiology, 71, 768-778. https://doi.org/10.1016/j.crad.2016.02.013
|
[26]
|
刘茜, 杨志刚, 李媛. 心肌梗死的心脏磁共振成像技术临床应用及其研究现状[J]. 磁共振成像, 2021, 12(8): 98-100+107.
|
[27]
|
蒋月薪, 郭应坤. 心脏磁共振技术在高原心脏病早期心肌损伤中的应用研究进展[J]. 实用临床医药杂志, 2021, 25(11): 120-123+128.
|
[28]
|
Klumpp, B., Hoevel-born, T., Fenchel, M., et al. (2009) Magnetic Resonance Myocardial Perfusion Imaging—First Experience at 3.0T. Eu-ropean Journal of Radiology, 69, 165-172. https://doi.org/10.1016/j.ejrad.2007.09.036
|
[29]
|
Tantawy, S.W., Mo-hammad, S.A., Osman, A.M., El Mozy, W. and Ibrahim, A.S. (2021) Strain Analysis Using Feature Tracking Cardiac Magnetic Resonance (FT-CMR) in the Assessment of Myocardial Viability in Chronic Ischemic Patients. The Interna-tional Journal of Cardiovascular Imaging, 37, 587-596.
https://doi.org/10.1007/s10554-020-02018-w
|
[30]
|
Kojonazarov, B., Isakova, J., Imanov, B., et al. (2012) Bosentan Reduces Pulmonary Artery Pressure in High Altitude Residents. High Altitude Medicine & Biology, 13, 217-223. https://doi.org/10.1089/ham.2011.1107
|
[31]
|
Anand, I.S., Prasad, B.A., Chugh, S.S., et al. (1998) Effects of In-haled Nitric Oxide and Oxygen in High-Altitude Pulmonary Edema. Circulation, 98, 2441-2445. https://doi.org/10.1161/01.CIR.98.22.2441
|
[32]
|
Mirrakhimov, A.E. and Strohl, K.P. (2016) High-Altitude Pulmo-nary Hypertension: An Update on Disease Pathogenesis and Management. The Open Cardiovascular Medicine Journal, 10, 19-27.
https://doi.org/10.2174/1874192401610010019
|
[33]
|
罗江秀. 高原性心脏病68例临床分析[J]. 医学信息(中旬刊), 2011, 24(9): 4342-4343.
|